Calliditas Therapeutics AB (0A5R.LSE) Q4 2023 Earnings

21FebConfirmed
Q4 2023
-0.97
-0.76
-0.55
-0.35

Details

Expected EPS
-0.965310949522206
Actual EPS
-0.34755148092
Surprise EPS
0.62
Surprise Percent
+64%

Description

Calliditas Therapeutics AB (0A5R.LSE) has reported earnings of -0.34755148092 per share for Q4 2023.

0 Comments

Share your thoughts